Both in Pharmaceuticals
Immuneering vs Greenwich LifeSciences
Over the past year IMRX returned −38.8% and GLSI returned +80.9%; their daily moves had a correlation of 0.26.
IMRX −38.8% GLSI +80.9%Growth of $1, one year, split-adjusted
| Metric | IMRX | GLSI |
|---|---|---|
| Price | $4.13 | $18.38 |
| Market cap | $267.2M | $269.8M |
| Today | −0.72% | −1.13% |
| 1 month | −17.2% | +17.3% |
| 6 months | −15.4% | −14.5% |
| Year to date | −37.2% | −12.5% |
| 1 year | −48.9% | +76.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $149.9M | $8.9M |
| Dividend yield | — | — |
| Volatility (60d) | 52.5% | 96.7% |
| Short % of float | 27.8% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).